PharmaCyte Biotech, Inc. 8-K/A
8-K/A · PharmaCyte Biotech, Inc. · Filed Nov 18, 2025
Documents
- 8-K
8-K/A
- EX-23.1
CONSENT OF STEPHANO SLACK LLC, INDEPENDENT AUDITOR OF Q/C
- EX-23.2
CONSENT OF MORISON COGEN LLP, INDEPENDENT AUDITOR OF Q/C
- EX-99.1
Q/C AUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2024 AND 2023, AND FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023, TOGETHER WITH THE NOTES THERETO AND REPORTS OF INDEPENDENT AUDITORS THEREON.
- EX-99.2
Q/C UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2025, AND FOR THE SIX MONTHS ENDED JUNE 30, 2025, TOGETHER WITH THE NOTES THERETO.
- EX-99.3
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
- EX-101.SCHpmcb-20250902.xsd
XBRL SCHEMA FILE
- EX-101.LABpmcb-20250902_lab.xml
XBRL LABEL FILE
- EX-101.PREpmcb-20250902_pre.xml
XBRL PRESENTATION FILE
- XML
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001683168-25-008512-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLpharmacyte_8ka_htm.xml
IDEA: XBRL DOCUMENT